Clinical Trials
1,126 trialsFORTITUDE-101
Amgen
HER Image
Amsterdam UMC, location VUmc
SAH
Ruijin Hospital
Nutrition Intervention Trials in Linxian Follow-up Study
National Institutes of Health Clinical Center (CC)
Hereditary Gastric Cancer Syndromes: An Integrated Genomic and Clinicopathologic Study of the Predisposition to Gastric Cancer
National Institutes of Health Clinical Center (CC)
BRIDGE-GC
The Catholic University of Korea
KITuKo
Medizinische Hochschule Brandenburg Theodor Fontane
A Phase Ib/II Clinical Study Evaluating HMPL-453 Tartrate as Monotherapy and in Combination With Chemotherapy or Toripalimab in Advanced Solid Tumors
Hutchmed
Study of CBX-12 in Subjects With Advanced or Metastatic Refractory Solid Tumors
Cybrexa Therapeutics
Savolitinib for Treating Gastric Cancer and Esophagogastric Junction Adenocarcinoma Patients
Hutchmed
GASPAR
Centre Francois Baclesse
LEAP-005
Merck Sharp & Dohme LLC
Phase II Study of PRL3-ZUMAB in Advanced Solid Tumors
National Cancer Centre, Singapore
Clinical Study of Cord Blood-Derived CAR-NK Cells in Gastric Cancer and Pancreatic Cancer
Zhejiang Provincial People's Hospital
Safety and Efficacy of Trastuzumab BS
Pfizer
StomachCancer
Sohag University
T-DXd_HER2Low
National Cancer Center Hospital East
RAMPART
Montefiore Medical Center
TraveraRTGx
Travera Inc
Multi-omics Sequencing in Neoadjuvant Immunotherapy of Gastrointestinal Tumors
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
TRACE
University Hospital, Rouen
Treatment of Cabotamig (ARB202) in Advanced Gastrointestinal Cancer Patients
Arbele Limited
KEYNOTE-585
Merck Sharp & Dohme LLC
KEYNOTE-585
Merck Sharp & Dohme LLC
Submucosal Pressure Ejection Endoscopic Dissection for Early Gastric Cancer: a Retrospective Cohort Study
Shanghai East Hospital
Prediction of Postoperative Complications and Survival in Gastric Cancer Using Preoperative Blood Markers
First Affiliated Hospital of Chongqing Medical University
TAS 102 in Combination With Ramucirumab in Advanced, Refractory Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma
H. Lee Moffitt Cancer Center and Research Institute
KEYNOTE-859
Merck Sharp & Dohme LLC
KLASS-09
Korea University Guro Hospital
A Study of Metastatic Gastrointestinal Cancers Treated With Tumor Infiltrating Lymphocytes in Which the Gene Encoding the Intracellular Immune Checkpoint CISH Is Inhibited Using CRISPR Genetic Engineering
Intima Bioscience, Inc.
TOX-FRAIL
Ankara Etlik City Hospital
LOGICA
UMC Utrecht
A Phase 1 Study of SHR-A1811 in Patients With Selected HER2 Expressing Tumors
Jiangsu HengRui Medicine Co., Ltd.
Multigene Germline Panel Testing in Gastric Cancer Patients in Portugal
Unidade Local De Saúde Do Norte Alentejano
Olaparib and Ramucirumab in Treating Patients With Metastatic or Locally Recurrent Gastric or Gastroesophageal Junction Cancer That Cannot Be Removed by Surgery
National Cancer Institute (NCI)
Dose-finding Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of SNB-101(SN-38) in Patients With Tumors
SN BioScience
A Phase 1 in Patients With HLA-A*0201+ and WT1+ Recurrent/Metastatic Cancers
Cue Biopharma
18F-FAPI-74 GI
SOFIE
Oral Cryotherapy Plus Acupressure and Acupuncture Versus Oral Cryotherapy for Decreasing Chemotherapy-Induced Peripheral Neuropathy From Oxaliplatin-Based Chemotherapy in Patients With Gastrointestinal Cancer
University of Washington
Helicobacter Pylori Infection and Gastric Diseases in Lao PDR: First Community-Wide Population-Based Study
Zero Helicobacter IGAN Network
Prehabilitation Plus ERAS in Gastric Cancer Surgery
The Affiliated Hospital of Qingdao University
PERIOP-PC
Stanford University
[68Ga]Ga-FAPI PET/CT in Gastric and Gastroesophageal Junctional Cancer
Aalborg University Hospital
GEN-001 in Combination With Avelumab for Patients With PD-L1 Positive Gastric Cancer
Genome & Company
Establishment and Effectiveness Evaluation of a Training System for Confocal Laser Endomicroscopy
Changhai Hospital
MK-3475-811
Merck Sharp & Dohme LLC
Evaluating Length of Treatment With PD-1/PD-L1 Inhibitor in Advanced Solid Tumors
University of Pittsburgh
Safety and Efficacy of Telatinib in Combination With Keytruda in Subjects With Advanced Stomach and Gastroesophageal Junction Cancers or Hepatocellular Carcinoma
Cedars-Sinai Medical Center
PREACT
Shanghai Cancer Hospital, China
A Study to Evaluate Nivolumab in Patients With Unresectable Advanced/Metastatic Gastric Cancer and Gastroesophageal Junction Cancer
Bristol-Myers Squibb